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Amphiphilic DNA Anchoring to
Membranes
Parts of this chapter were published in: Adv. Healthc. Mater. 2019, 1900389.
2. Amphiphilic DNA Anchoring to Membranes
2.1 Introduction
The biological membrane, known as plasma membrane, separates the cell cytosol
from the extracellular environment. The basic building block of the mammalian
cell membrane is a semi permeable lipid bilayer. Phospholipids, composed of a
polar head with phosphate group and two hydrophobic fatty acid tails, contribute
as a major part to the membrane. They form a bilayer by assembling hydrophobic
tails together while their hydrophilic heads facing either cytosol or extracellular
fluid. Most of the phospholipids of the cell membrane are unsaturated. Choles-
terol, another lipid component, is embedded between phospholipid molecules
and regulates membrane stiffness and stability. Although the cell membrane is
a closed, non leaky bilayer system, the individual phospholipid molecules are
dynamic and mobile. They move freely in two dimensions, providing cell mem-
brane with the fluidity. Cell membrane is not just a homogeneous unsaturated
lipid bilayer. It also has certain lipids enriched domains called lipid raft. Choles-
terol, sphingomyelin and tightly packed saturated phospholipids form these lipid
rafts and they are more stable and less fluid than the rest of membrane.[1] When
embedded with specific membrane proteins, these lipid rafts are essential for
cellular functions such as signal transduction and endocytosis. Apart from lipids,
cell membrane contains many proteins. These proteins make up about half of
the cellular membrane by mass and are responsible for many membrane func-
tions, like cell signaling,[2] cell-cell interactions and nutrient transportation.[3, 4]
Some of the lipids, proteins and other membrane constituents recycle between
the plasma membrane and intracellular endocytic compartments[5, 6] or between
different cells within the body by extracellular vesicles, known as exosomes.
Similar with the cell membrane, liposome is a small synthetic spherical structure
with an aqueous lumen sealed by a bilayer membrane. Its bilayer can be con-
structed from phospholipids and cholesterol, similar as a biological membrane.
The composition of liposome bilayer determines its rigidity. Unsaturated phos-
phatidylcholine species (for instance, DOPC and DOPE) are more fluidic thus less
stable as compared with saturated phospholipids with long acyl chains (DPPC as
an example) which forms a rigid and rather impermeable bilayer structure.[7] Li-
posomes have been long used in the clinic as nanocarriers for drug delivery, due to
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their biocompatibility, self-assembly property and high drug loading capacity.[8]
Up to date, many liposome based products are available on the market for clinical
application, e.g., Doxil®, Ambisome®, Onivyde™, etc.[9]. To further improve their
colloidal stability and in vivo circulation time, conventional liposomes are then
PEGylated by adding 5 mol% PEG-lipid to the total lipid content.[10, 11] Moreover,
liposome membrane can be easily modified with many ligands, for instance DNA,
peptides or other small molecules (Fig. 2.1).[12] As being highly programmable
and functional, DNA is a quite attractive membrane modification. The most sim-
ple way to modify liposome surfaces with DNA is to anchor amphiphilic DNA to its
bilayer by hydrophobic interaction between hydrophobic part of the amphiphilic
DNA and membrane lipids.[13, 14, 15, 16, 17]
Previous reports of our group showed that dodec-1-yne-modified deoxyuridine
nucleotides could be incorporated into common DNA sequences[18] and the re-
sulting lipid DNA could be anchored to phospholipid-based liposome (DOPC,
DOPE, cholesterol) membrane in a straightforward manner[19]. Therefore, as
an extension of this work, we here explored the ability of lipid DNA anchoring
to different formulations of liposomes, namely, liposome made from unsatu-
rated phospholipids (DOPC:DOPE:cholesterol = 2:1:1), saturated phospholipids
(DPPC:cholesterol = 2:1) and their PEGylated form. Besides this, we further chal-
lenged to anchor lipid DNA to a more complicated bilayer system: the cell mem-
brane. To anchor DNA to membranes, oligonucleotides were conjugated with
either four (U4T23, U4T) or six (U6T) lipid modified deoxyuridine nucleotides.
Their sequences and the complementary sequences are detailed in Table 2.1 and
Fig. 2.2a.
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Figure 2.1 | Schematic illustration of liposome surface modification.[12] (a) Conventional liposome
made of phospholipids; (b) PEGylated liposome contains a layer of polyethylene glycol (PEG) at the
surface; (c) Targeted liposome contains a specific targeting ligand; (d) Multi-functional liposome.
2.2 Results and Discussions
2.2.1 Lipid DNA Anchoring to Liposome Membrane
To prove anchoring of lipid DNA to liposomal membranes, fluorescence resonance
energy transfer (FRET) method established in previous work[19] was employed.
Lipid DNA (U4T) was first anchored to the liposome membrane (incorporated
with a fluorophore as an acceptor dye) and then hybridized with its complemen-
tary strand labeled with a donor dye. Hybridization should bring the donor and
the acceptor dye close enough to initiate FRET, as illustrated in Fig. 2.2b, (1).
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CU4T FAM GCAGACGAATCCGC 5-FAM
CU4T ATTO488 GCAGACGAATCCGC 3-ATTO488
Table 2.1 | Sequences and modifications of lipid DNA used in this chapter.
Figure 2.2 | (a) Schematic illustration of lipid DNA used in this chapter. U represents dodecyne
modified deoxyuridine nucleotide. The green star symbolizes fluorophore-modified DNA strands.
(b) Schematic illustration of lipid DNA anchoring proof and its quantification on liposomal mem-
brane. (1) FRET between a donor dye (green dot) and an acceptor dye (red dot) occurred on
liposome membrane upon hybridization of lipid DNA with its complementary strand. (2) Lipid
DNA quantification on liposome membrane after dialysis purification.
For quantification of membrane anchored lipid DNA, after dialysis of free unhy-
bridized strands, fluorescence intensity of the liposome solution was recorded
and compared with a calibration curve of free complementary strand to calculate
the membrane anchored lipid DNA and its hybridization efficiency, see Fig. 2.2b,
(2).
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Lipid DNA Anchoring to Unsaturated Liposome
To prove the anchoring of U4T to the membrane of liposome made of unsaturated
phospholipids, U4T was first anchored to the liposome (DOPC:DOPE:rhodamine-
DHPE:cholesterol = 2:1:0.09:1, d = 100 nm). To do this, dried U4T was mixed with
phospholipids in ethanol. After solvent evaporation, freeze-drying cycles and size
reduction by extrusion, U4T anchored liposomes were prepared. The resulting
liposomes were hybridized with a complementary DNA modified with ATTO488
at the 3’ end (CU4T ATTO488). The hybridization of U4T and CU4T ATTO488
brought ATTO488 in close contact to rhodamine, initiating FRET. Upon lysis of the
liposomes with 0.3% Triton X-100, the distance between ATTO488 and rhodamine
increased, consequently decreasing the FRET efficiency, and hence proving the
successful strand hybridization on the liposome surface (Fig. 2.3a). In addition, a
gradual decrease of liposome surface zeta potential (Fig. 2.13b) was indicative of
successful U4T anchoring and hybridization. We subsequently quantified DNA
anchoring efficiency to the liposomal membrane by hybridizing U4T-anchored
liposomes with CU4T FAM. After dialysis and removal of the non-hybridized
components, FAM fluorescence intensity of the liposome in comparison with
the calibration curve of free CU4T FAM allowed us to calculate the amount of
CU4T FAM in the liposome solution (Fig. 2.3b). This amount corresponds to
roughly half of the U4T initially employed in the functionalization process and is
an expected value, as we suppose that lipid DNA also anchored to the inner leaflet
of the liposome membrane, inaccessible to CU4T FAM hybridization. Based on
Eq. 2.1 and 2.2, ca. 500 strands are estimated to be on each liposome surface.
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Figure 2.3 | Lipid DNA anchoring to unsaturated liposomal membrane. (a) FRET efficiency of
ATTO488 and rhodamine occurred on liposome. After adding 0.3% Triton X-100, FRET efficiency
decreased. D: maximum emission wavelength of donor dye ATTO488; A: maximum emission
wavelength of acceptor dye rhodamine. Black curve: before Triton X-100 addition; red curve: after
Triton X-100 addition. (b) Fluorescence intensity of CU4T FAM in liposome solution after dialysis of
free CU4T FAM. Black curve: relative fluorescence intensity of U4T anchored liposome solution.
Red curve: relative fluorescence intensity of non U4T anchored control liposome solution. Inset
graph is the calibration curve of free CU4T FAM. Black: curve plotted from experimental data; red:
fitted curve.
Lipid DNA Anchoring to Saturated Liposome
After confirming that U4T is able to anchor to unsaturated liposomes, we further
tried to anchor it to a saturated liposome composition (DPPC:cholesterol = 2:1)
with less membrane fluidity. Again, FRET of ATTO488 and rhodamine was used
to prove anchoring. Quite unexpectedly, we noticed a very weak FRET signal
as compared with that of unsaturated liposomes. After lysis with Triton X-100,
instead of decreasing, acceptor rhodamine fluorescence intensity increased two
fold (Fig. 2.4a). To address the reason for this behavior, rhodamine-DHPE in-
corporated liposomes wihout U4T anchoring were prepared and only negligible
rhodamin signal was observed. However, after Triton X-100 treatment, its signal
significantly increased up to 10 times (Fig. 2.4b). This measurement indicated
that rhodamine-DHPE incorporated into DPPC liposome domains, thus its flu-
orescence was quenched due to the high local concentration. Because of this
quenching effect, rhodamine-DHPE is not a suitable acceptor for DPPC liposomes.
Therefore, another lipophilic fluorophore, Nile red was employed as the acceptor.
After Triton X-100 lysis, decrease of Nile red signal and a large shift of its emission
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peak was noticed (Fig. 2.4c). Whereas this is considered as an effect induced by
Triton X-100, not by the FRET process, as this was also seen from a bare liposome
with only Nile red embedded (Fig. 2.4d). We reasoned that Triton X-100 changes
the environment of Nile red by which its fluorescence is strongly influenced. Be-
sides, an increase of ATTO488 emission signal was seen, but it was decreased for
the control liposome without U4T anchoring (Fig. 2.4e). This is an indication
for the occurrence of FRET because after Triton X-100 addition, the liposomes
disassembled and FRET from ATTO488 to Nile red disappeared, thus emission of
ATTO488 itself increased which is not sensitive to the environmental polarity. In
control liposomes, since there was no FRET, only decrease of ATTO488 could be
seen as a result of sample dilution by Triton X-100. Although it is not easy to probe
lipid DNA anchoring to saturated liposome by the FRET method, the direct quan-
tification method by measuring fluorescent intensity of its complementary DNA
could definitely imply its successful anchoring and hybridization. Thus, anchored
U4T was quantified by hybridizing with CU4T FAM and a half anchoring to outer
leaflet and full hybridization was also detected (Fig. 2.4f), as for the unsaturated
liposome.
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Figure 2.4 | Lipid DNA anchoring to DPPC liposomal membrane. (a) FRET phenomenon of ATTO488
and rhodamine on DPPC liposome. After adding 0.3% Triton X-100, rhodamine signal increased.
D: maximum emission wavelength of donor dye ATTO488; A: maximum emission wavelength of
acceptor dye rhodamine. Black curve: before Triton X-100 addition; red curve: after Triton X-100
addition. (b) rhodamine-DHPE signal change after DPPC liposome lysis. After 0.3% Triton X-100,
rhodamine signal significantly increased. Black curve: before Triton X-100 addition; red curve:
after Triton X-100 addition. (c) FRET phenomenon of ATTO488 and Nile red on DPPC liposome.
D: maximum emission wavelength of donor dye ATTO488; A: maximum emission wavelength of
acceptor dye Nile red. Black curve: before Triton X-100 addition; red curve: after Triton X-100
addition. (d) Decrease of Nile red signal and shift of its emission wavelength after adding 0.3%
Triton X-100 to Nile red embedded DPPC liposome. (e) Excitation of Nile red incorporated DPPC
liposome with no U4T anchoring. Black curve: before Triton X-100 addition; red curve: after Triton
X-100 addition. (f) Fluorescence intensity of CU4T FAM in liposome solution after dialysis of free
CU4T FAM. Black curve: relative fluorescence intensity of U4T anchored liposome solution. Red
curve: relative fluorescence intensity of non U4T anchored control liposome solution. Inset graph
is the calibration curve of free CU4T FAM. Black: curve plotted from experimental data; red: fitted
curve.
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Lipid DNA Anchoring to PEGylated Liposome
For therapeutic applications, liposomes are widely formulated with additional 5%
PEG-lipid as PEGylation increases its circulation time and improves the enhanced
permeation retention (EPR) effect. Thus, here we tested whether lipid DNA could
also anchor to PEGylated liposomes with the hybridization method as shown
above. The signal of CU4T FAM in U4T anchored liposome solution was extremely
high whereas it was hardly detectable for the non-anchored control liposome in
both PEGylated non-saturated (Fig. 2.5a) and saturated liposomes (Fig. 2.5b).
Quantification of CU4T FAM signals indicated that PEG layer had no effect on
U4T anchoring in these liposomes.
Figure 2.5 | Lipid DNA anchoring on PEGylated liposomal membrane. Fluorescence intensity
of CU4T FAM from the liposome solution after dialysis of free CU4T FAM. Black curve: relative
fluorescence intensity of U4T anchored liposome solution. Red curve: relative fluorescence intensity
of non U4T anchored control liposome solution. Inset graph is the calibration curve of free CU4T
FAM. Black: curve plotted from experimental data; red: fitted curve. (a) Unsaturated liposome (b)
Saturated liposome.
2.2.2 Lipid DNA Anchoring to Cell Membrane
Since lipid DNA can be anchored to a variety of liposome membranes, we fur-
ther challenged the system to tether to a more complicated membrane: cellular
membranes. To do this, we incubated HeLa cells with a micellar solution of FAM-
modified lipid DNA (U4T23) for 20 min and analyzed cells by flow cytometry after
sufficient washing. To rule out nonspecific cellular adsorption and internaliza-
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tion of the lipid DNA, a control DNA sequence without lipid tail (CU4T FAM)
was measured in addition. Analysis of the FAM emission signal clearly indicated
that cells incubated with U4T23 (Fig. 2.6a, orange) showed significantly higher
fluorescence intensity as compared to CU4T FAM treated control (Fig. 2.6a, blue)
or untreated cells (Fig. 2.6a, red). This significant signal difference highlights the
strong and selective interaction of lipid DNA with the cell surface. To evaluate the
hybridization feasibility of surface anchored lipid DNA, U4T anchored cells were
exposed to CU4T FAM. Flow cytometry data showed that only cells incubated
with both U4T and CU4T FAM showed an increased fluorescence signal (Fig. 2.6b,
orange). In stark contrast, untreated cells (Fig. 2.6b, red) and those incubated
only with CU4T FAM in the absence of the U4T anchors (Fig. 2.6b, blue), revealed
considerably lower fluorescence, eliminating nonspecific cellular adsorption or in-
ternalization of the CU4T FAM itself as source for the increased signal. Successful
anchoring of lipid DNA to another cell line, MDA-MB-468 proved our anchoring
method quite universal for cellular membrane modification (Fig. 2.14).
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Figure 2.6 | Characterization of lipid DNA anchoring to cell membrane. (a) Top: schematic illus-
tration of anchoring U4T23 on HeLa cells. Bottom: flow cytometry analysis of U4T23 anchoring.
HeLa cells were incubated with U4T23 for 20 min before flow cytometry measurement. As a control,
cells were also incubated with CU4T FAM for 20 min. Red: untreated control cells; Blue: cells with
CU4T FAM; Orange: cells with U4T23. (b) Top: schematic illustration of hybridization of U4T on
HeLa cells. Bottom: flow cytometry analysis of U4T hybridization on HeLa cells. HeLa cells were
incubated with or without U4T for 20 min, then CU4T FAM was added and after an incubation
period of 15 min, flow cytometry measurements were performed. Red: untreated control cells; Blue:
cells without U4T; Orange: cells with U4T.
Homogeneous cell membrane distribution of CU4T was unambiguously con-
firmed by confocal laser scanning microscopy (CLSM), revealing that U4T was
uniformly located on the cell membrane and accessible for hybridization (Fig.
2.7).
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Figure 2.7 | CLSM micrograph of CU4T FAM distribution on U4T anchored HeLa cell membrane.
CU4T FAM was incubated with U4T anchored HeLa for 15 min. Scale bar: 40 µm.
Moreover, to demonstrate the hydrophobic interaction strength of the lipophilic
tails in lipid DNA and the cellular phospholipid layer, lipid DNA anchoring stability
was recorded over time. Therefore, cells were incubated with U4T for different
periods of time at 4 °C and hybridized with CU4T FAM afterwards. Subsequent
flow cytometry analysis indicated the relative remaining amount of U4T on the
cell membrane. Evidently, U4T anchorage was very stable on the cell surface
for up to 3 h and there was a minor decrease after 4 h incubation (Fig. 2.8a).
As low temperature decrease cell viability, thus a longer incubation time period
was performed at 37 °C. Surprisingly, even up to 15 h, there was no obvious loss
of anchored U4T. The significantly reduced signals for the measurement after
24 h possibly stem from lipid DNA degradation by nucleases in the cell growth
medium, cell proliferation, or spontaneous turnover of membrane lipids (Fig.
2.8b). To study whether increasing lipid DNA hydrophobicity has an effect on
its membrane stability, lipid DNA with six modified deoxyuridine nucleotides
(U6T) was synthesized and incubated with cells at 4 °C and 37 °C for the same
periods of time as U4T. U6T showed a more stable anchoring than U4T after 4 h
incubation at 4 °C (Fig. 2.8c). Quite surprisingly, when incubated with cells at 37
°C, a decrease of stability was noticed (Fig. 2.8d). This might be an effect of higher
cellular toxicity of U6T as compared to U4T (data not shown).
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Figure 2.8 | Characterization of lipid DNA membrane anchoring stability. Seeded HeLa cells were
incubated with lipid DNA for 15 min, 1 h, 2 h, 3 h or 4 h at 4 °C or incubated for 15 min, 1 h, 4
h, 15 h, or 24 h at 37 °C. Afterwards, each sample was incubated with CU4T FAM for 15 min and
subsequently subjected to flow cytometry and CU4T FAM signal was compared. (a) U4T at 4 °C; (b)
U4T at 37 °C; (c) U6T at 4 °C; (d) U6T at 37 °C.
Lipid DNA Cellular Toxicity
For any biological application, cellular toxicity is of significant importance and
has to be tested before any further steps. Therefore, the effect of the U4T anchor
on HeLa cell over 48 h was tested. Fig. 2.9 indicated that toxicity of U4T is concen-
tration dependent and at up to 10 µM, its effect on cell viability is moderate.
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Figure 2.9 | Characterization of toxicity of lipid DNA anchoring to cell membrane. Seeded HeLa
cells were incubated with varied concentration of U4T for 48 hours at 37 °C. Afterwards, cell viability
was evaluated with XTT assay. Error bars indicate SD of the mean (n = 3).
2.3 Conclusion
Amphiphilic DNA spontaneously inserts into membranes. The driving force is the
hydrophobic interactions of the aliphatic chains of nucleobase and the hydropho-
bic part of the membrane. The nucleic acid moieties of membrane-anchored
amphiphilic DNA are free to hybridize with their complementary molecules from
the aqueous environment. Hydrophobic moieties of these amphiphilic DNA can
be cholesterol molecules[20, 21], single hydrocarbon chains[22, 23] or double hydro-
carbon chains[24, 25]. This study here demonstrated that amphiphilic DNA with
four hydrocarbon chains can anchor to both saturated (DOPC:DOPE:cholesterol
= 2:1:1) and unsaturated liposome membrane (DPPC:cholesterol = 2:1), even
to PEGylated formulations. Quantification of these membrane anchored lipid
DNA revealed that almost half of input lipid DNA locates in the outer leaflet of
liposome and is full accessible to its complementary sequence. It was also ob-
served by confocal microscopy that lipid DNA homogeneously anchors to the
cell membrane and this anchoring is applicable to several cell lines. Over time
test of cellular membrane lipid DNA reveals a high anchoring stability for several
hours. When increasing the hydrophobicity of lipid DNA by adding two more
hydrocarbon chains, its membrane anchoring stability is further improved but
cellular biocompatibility is compromised.
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2.4 Experimental Section
2.4.1 Materials
All chemicals and reagents purchased from commercial suppliers were used with-
out further purification unless noted. 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dipalmitoyl-
sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethano
lamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) (DSPE-PEG2k),
cholesterol (plant derived) and polycarbonate membranes with diameter of 100
nm were acquired from Avanti Polar lipids. Nile red, Triton X-100 was purchased
from Sigma Aldrich. Sephadex G-25 column PD-10 was from GE Healthcare. Dul-
becco’s Modified Eagle Medium (DMEM), fetal bovine serum, and PBS were pur-
chased from Lonza. Lissamine™ Rhodamine B 1,2-Dihexadecanoyl-sn-Glycero-
3-Phosphoethanolamine, Triethylammonium salt (rhodamine DHPE), phenol
red free DMEM, Penicillin/streptomycin and Trypsin were acquired from Thermo
Fisher Scientific. µ-Slide 8 well was obtained from ibidi. HeLa and MDA-MB-
468 cell lines and XTT cell proliferation assay kit were purchased from ATCC.




Figure 2.10 | Structures of lipids used in this chapter.
2.4.2 Lipid DNA Synthesis and Characterization
Figure 2.11 | Synthetic steps of lipid-DNA. a: C12H12, Palladium-tetrakis(triphenylphosphine), CuI,
DIPA, DMF, RT; b: 2-Cyanoethyl N,N-diisopropylchlorophosphoramidite, DIPEA, CH2Cl2, RT; c:
DNA synthesizer; d: purification.
5-(dodec-1-ynyl) deoxyuracil and 5-(dodec-1-ynyl) deoxyuracil phosphoramidite
(Fig. 2.11) were synthesized as reported previously.[18] Then the modified uracil
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phosphoramidite (0.15 M) was dissolved in acetonitrile, in the presence of 3Å molec-
ular sieves, and the prepared solution was directly connected to a DNA synthesizer
(ÄKTA OligoPilot Plus, GE Healthcare (Uppsala, Sweden)). Oligonucleotides were
synthesized on a 50 µmol scale using standard β-cyanoethylphosphoramidite
coupling chemistry. Deprotection and cleavage from the PS support was car-
ried out by incubation in concentrated aqueous ammonium hydroxide solution
overnight at 65 °C. Following deprotection, the oligonucleotides were purified by
reverse-phase chromatography, using a C15 RESOURCE RPC 3 mL reverse phase
column (GE Healthcare) through a custom gradient elution (A: triethylammo-
nium acetate (TEAAc, 100 mM) and MeCN (5%), B: TEAAc (100 mM) and MeCN
(65%)). Fractions were desalted using centrifugal dialysis membranes (MWCO
3000 g·mol−1). For FAM modification, 5’-fluorescein phosphoramidite (Glen Re-
search) was dissolved in MeCN according to manufacturer’s recommendation;
functionalization was performed using standard β-cyanoethylphosphoramidite
coupling chemistry. Oligonucleotide concentrations were determined by UV
absorbance using extinction coefficients. Finally, the identity and purity of the
oligonucleotides was confirmed by MALDI-TOF mass spectrometry (Fig. 2.12).
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Figure 2.12 | MALDI-TOF mass spectra of lipid-DNA used in the experiments. (a) U4T23 (calcd.:
9314 g·mol−1, found: 9451 g·mol−1), (b) U4T (calcd.: 6033 g·mol−1, found: 6096 g·mol−1), (c) U6T
(calcd.: 6915 g·mol−1, found: 6976 g·mol−1)
2.4.3 Liposome Preparation
31.23 nmol of U4T in MQ was dried by lyophilisation in a 10 mL glass vial. Then
248 µL mixture of DOPC, DOPE, cholesterol (2:1:1, 10.08 mM) in ethanol or 369
µL mixture of DPPC and cholesterol (2:1, 6.77 mM) in ethanol was added to
U4T dry layer. The molar ratio of liposome lipids (cholesterol is not included)
with U4T is 80. Ethanol was evaporated by a dry N2 stream. Dried lipid films
were then re-hydrated with PBS buffer. Lipid emulsions were sonicated for 5
min, then subjected to 5 freeze-thaw cycles and 21 times extrusion through a 100
nm polycarbonate membrane by a Mini Extruder (Avanti Polar lipids) at room
temperature.
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2.4.4 FRET Assay
For FRET analysis of U4T anchoring to DOPC DOPE liposomes, 3% Rhodamine-
DHPE was included in the liposome compositions. For FRET analysis of U4T
anchoring to DPPC liposome, 3% of Nile red was included in the liposome com-
positions. Then CU4T ATTO488 was added to the liposome solution at equivalent
amount of outside U4T and hybridized using a thermal gradient (40 °C, 15 min;
-1 °C per min utill 4 °C). Afterwards, free CU4T ATTO488 was removed by dialy-
sis (Slide-A-Lyzer™ Dialysis Cassettes, 100k) and the emission spectra of CU4T
ATTO488 and Rhodamine-DHPE were measured by SpectraMax M3 (Molecu-
lar Devices) plate reader. To disassemble the liposomes, 0.3% Triton X-100 was
added to the liposome solution and the emission spectra of CU4T ATTO488 and
Rhodamine-DHPE was recorded again.
2.4.5 Surface Anchored U4T Quantification
To quantify the amount of lipid DNA on liposome membrane, liposomes with
or without U4T anchoring were prepared as described above. CU4T FAM (6.25
nmol) was added to liposome solution (100 µL) to allow overnight hybridization.
Unhybridized free CU4T FAM molecules were removed by dialysis. Then puri-
fied liposome solution was diluted with PBS and its fluorescence intensity was
measured. Fluorescence intensity of a series free CU4T FAM concentrations was
also measured resulting in a calibration curve. Then CU4T concentration in the
liposome solution was calculated based on this calibration curve.
2.4.6 Calculation of U4T on Liposome








where d is the diameter of the liposome (outer surface), h is the thickness of the
bilayer about 5 nm and α is the lipid head group area. For phosphatidylcholine, α
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For liposomes with a diameter of 100 nm, Ntotal is estimated to be 8×104. For lipid
DNA and lipid ratio of 80, there are roughly 500 lipid DNA molecules outside per
liposome.
2.4.7 Characterization of Lipid DNA Anchored Liposome
To characterize liposomes, DOPC DOPE liposomes were used as a representative
liposome composition. Liposomes were prepared as described at a concentra-
tion of 5 mM and diluted to 50 µM with PBS and measured with dynamic light
scattering and a diameter of 100 nm by intensity was found. As an additional
method to show U4T anchoring and membrane hybridization, zeta potential of
bare liposomes, U4T anchored liposomes and CU4T ATTO488 hybridized U4T
liposomes was measured.
Figure 2.13 | Characterization of liposome. (a) Size distribution of preprared liposome; (b) Zeta
potential of different liposome. bare: DOPC DOPE liposome; U4T: DOPC DOPE liposome anchored
with U4T; Hyb-U4T: U4T liposome hybridized with CU4T ATTO488.
2.4.8 Cell Culture
HeLa cells were maintained in DMEM supplemented with fetal bovine serum
(10%) and penicillin/streptomycin (1%) and cultured at 37 °C with 5% CO2 and
100% humidity.
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2.4.9 Evaluation of Toxicity
All samples were sterilized by 0.22 µm syringe filter before cell experiments. HeLa
cells were seeded in a 96 well plate at a density of 1×104 per well overnight. Then
U4T in PBS solution was added to fresh medium at varied concentrations (in
triplicate) then replaced old medium in well plate. After 48 hours, medium was
removed and 50 µL of XTT solution pre-mixed with PMS was added to each well.
Afterwards, the plate was incubated for 2 hours at 37 °C. Absorbance at 450 nm
and 630 nm was recorded.
2.4.10 Anchoring Lipid DNA to Cell Membrane
Confocal Microscopy Sample Preparation: For U4T anchoring, 300 µL HeLa cells
were seeded at µ-Slide 8 well overnight and incubated with U4T (4 µM) for 20 min
then with CU4T FAM for 15 min. Cells were rinsed with PBS 3 times and replaced
with phenol red free DMEM. Imaging was performed on a confocal laser scanning
microscope (STP8, Leica) and analyzed by ImageJ.
Flow Cytometry Measurements: For U4T23 anchoring, cells detached to a single
cell suspension (105 mL−1) were incubated with U4T23 (2 µM) for 20 min. For
hybridization experiments on the cell surfaces, after incubation with U4T (4 µM)
for 20 min, cells were further incubated with CU4T FAM (4 µM) for 15 min to allow
hybridization between U4T on cells and CU4T FAM in solution. After incubation
and 3 times rinsing with PBS buffer, cells were measured with the flow cytometer
(BD Accuri™ C6, DB Biosciences) with 1×104 events collected.
2.4.11 Lipid DNA Stability on Cell Membrane
To test lipid DNA anchoring stability on cell membranes, HeLa cells were seeded
at 12 well plate at a density of 1×105 overnight. Next day, cells were incubated with
U4T or U6T (4 µM) for 15 min, 1 h, 4 h, 15 h, and 24 h at 37 °C. After the desired
incubation time, cells were incubated with CU4T FAM (4 µM) for 15 min at 37 °C
to allow hybridization. For 4 °C experiments, cells were incubated with U4T or
U6T (4 µM) for 15 min, 1 h, 2 h, 3 h, and 4 h at 4 °C then hybridized with CU4T
FAM (4 µM) for 15 min at 4 °C. After hybridization, cells were washed 3 times with
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PBS and detached before they were subjected to flow cytometry measurements
with 10000 events collected.
2.4.12 Hybridization on MDA-MB-468 cell
MDA-MB-468 cells were seeded in 12 well plate and incubated with U4T for
20 mins. After sufficient rinsing with PBS buffer, CU4T FAM was added and
hybridization was allowed at 37 °C for 15 min. Cells were then detached, rinsed
and subjected to flow cytometry measurement.
Figure 2.14 | Flow cytometry analysis of DNA hybridization on MDA-MB-468 cells. Red: untreated
control cells; Blue: cells without U4T; Orange: cells with U4T.
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